Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Novel Influenza A (H1N1) Surveillance Registry
Novel Influenza A (H1N1) Surveillance Registry
Status: Enrolling
Updated:  4/13/2016
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Novel Influenza A (H1N1) Surveillance Registry
Novel Influenza A (H1N1) Surveillance Registry
Status: Enrolling
Updated: 4/13/2016
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
Quality Food Centers #101
mi
from
Belfair, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
Quality Food Centers #101
mi
from
Belfair, WA
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
Cheney-Owl Pharmacy
mi
from
Cheney, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
Cheney-Owl Pharmacy
mi
from
Cheney, WA
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
Kirk's Pharmacy
mi
from
Eatonville, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
Kirk's Pharmacy
mi
from
Eatonville, WA
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
Quality Food Centers #851
mi
from
Edmonds, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
Quality Food Centers #851
mi
from
Edmonds, WA
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
Lopez Island Pharmacy
mi
from
Lopez Island, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
Lopez Island Pharmacy
mi
from
Lopez Island, WA
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
Kelley-Ross Pharmacy
mi
from
Seattle, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
Kelley-Ross Pharmacy
mi
from
Seattle, WA
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
ReliantRx
mi
from
Spokane, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
ReliantRx
mi
from
Spokane, WA
Click here to add this to my saved trials
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated:  7/11/2016
Tieton Village Drug
mi
from
Yakima, WA
Project IMPACT Immunizations (IMProving America's Communities Together)
Project IMPACT Immunizations (IMProving America's Communities Together)
Status: Enrolling
Updated: 7/11/2016
Tieton Village Drug
mi
from
Yakima, WA
Click here to add this to my saved trials
Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults
Phase 1 Evaluation of the Safety and Immunogenicity of Live Influenza A Vaccine H7N9 (6-2) AA ca Recombinant (A/Anhui/1/2013 (H7N9) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H7N9 Disease in the Event of a Pandemic
Status: Enrolling
Updated:  7/26/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults
Phase 1 Evaluation of the Safety and Immunogenicity of Live Influenza A Vaccine H7N9 (6-2) AA ca Recombinant (A/Anhui/1/2013 (H7N9) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H7N9 Disease in the Event of a Pandemic
Status: Enrolling
Updated: 7/26/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Jackson, TN
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
El Paso, TX
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated:  8/1/2016
mi
from
Coquitlam,
A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Status: Enrolling
Updated: 8/1/2016
mi
from
Coquitlam,
Click here to add this to my saved trials
Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle
A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity of Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle
Status: Enrolling
Updated:  8/8/2016
The Hope Clinic
mi
from
Decatur, GA
Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle
A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity of Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle
Status: Enrolling
Updated: 8/8/2016
The Hope Clinic
mi
from
Decatur, GA
Click here to add this to my saved trials
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated:  11/21/2016
Radiant Research, Inc.
mi
from
Atlanta, GA
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated: 11/21/2016
Radiant Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated:  11/21/2016
Clinical Research Advantage, Inc/Ridge Family Practice
mi
from
Council Bluffs, IA
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated: 11/21/2016
Clinical Research Advantage, Inc/Ridge Family Practice
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated:  11/21/2016
Johnson County Clin-Trials
mi
from
Lenexa, KA
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated: 11/21/2016
Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated:  11/21/2016
Central Kentucky Researcch Associates, Inc.
mi
from
Lexington, KY
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated: 11/21/2016
Central Kentucky Researcch Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated:  11/21/2016
Radiant Research, Inc.
mi
from
Edina, MN
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated: 11/21/2016
Radiant Research, Inc.
mi
from
Edina, MN
Click here to add this to my saved trials
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated:  11/21/2016
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant
Status: Enrolling
Updated: 11/21/2016
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Idylla IFV-RSV Panel Clinical Testing
Idylla Respiratory (IFV-RSV) Panel Clinical Testing and Sample Collection Protocol in Support of 510(k) Premarket Submission
Status: Enrolling
Updated:  11/21/2016
Sacred Heart Hospital - Pensacola
mi
from
Pensacola, FL
Idylla IFV-RSV Panel Clinical Testing
Idylla Respiratory (IFV-RSV) Panel Clinical Testing and Sample Collection Protocol in Support of 510(k) Premarket Submission
Status: Enrolling
Updated: 11/21/2016
Sacred Heart Hospital - Pensacola
mi
from
Pensacola, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects
A Phase III, Multicenter, Uncontrolled, Open Label Study to Evaluate Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
mi
from
Cambridge, MA
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects
A Phase III, Multicenter, Uncontrolled, Open Label Study to Evaluate Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
mi
from
Cambridge, MA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers
A Phase I, Randomized, Placebo-Controlled, Four-Way Crossover Study to Evaluate the Effect of Intravenous (IV) Zanamivir on Cardiac Conduction as Assessed by 12-lead Electrocardiogram (ECG) With Moxifloxacin as a Positive Control in Healthy Volunteers
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Austin, TX
A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers
A Phase I, Randomized, Placebo-Controlled, Four-Way Crossover Study to Evaluate the Effect of Intravenous (IV) Zanamivir on Cardiac Conduction as Assessed by 12-lead Electrocardiogram (ECG) With Moxifloxacin as a Positive Control in Healthy Volunteers
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Las Vegas, NV
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Austin, TX
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Miami, FL
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Stockbridge, GA
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Rochester, NY
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Cleveland, OH
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Truro,
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Truro,
Click here to add this to my saved trials
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
Burden of Mild Outcomes Due to Influenza in the United States, July 2000 Through April 2009 and October 2010 to May 2011
Status: Enrolling
Updated:  1/9/2017
GSK Investigational Site
mi
from
Bethesda, MD
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
Burden of Mild Outcomes Due to Influenza in the United States, July 2000 Through April 2009 and October 2010 to May 2011
Status: Enrolling
Updated: 1/9/2017
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Status: Enrolling
Updated:  1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Status: Enrolling
Updated: 1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Status: Enrolling
Updated:  1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Status: Enrolling
Updated: 1/10/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
Phase 1, Double Blind, Randomized, Placebo Controlled Study to Assess Safety and Immunogenicity of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults.
Status: Enrolling
Updated:  2/1/2017
Florida Research Network
mi
from
Gainesville, FL
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
Phase 1, Double Blind, Randomized, Placebo Controlled Study to Assess Safety and Immunogenicity of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults.
Status: Enrolling
Updated: 2/1/2017
Florida Research Network
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Athens, AL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Athens, AL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Birmingham, AL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Gulf Shores, AL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Huntsville, AL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Tuscumbia, AL
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Tuscumbia, AL
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Phoenix, AZ
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Tucson, AZ
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Little Rock, AR
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Canoga Park, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Canoga Park, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Costa Mesa, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Diamond Bar, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Diamond Bar, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Gold River, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Gold River, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Greenbrae, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Hawaiian Gardens, CA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Hawaiian Gardens, CA
Click here to add this to my saved trials